Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that people with incurable secondary breast cancer have access to world-leading treatments.

NHS England announced in April 2025 that eligible women with secondary breast cancer could soon have access to a new targeted treatment, capivasertib, used alongside fulvestrant, on the National Health Service.

In May, NHS England announced the world’s first roll out of liquid biopsy testing, which is now available for all eligible breast cancer patients, and which aims to speed up diagnosis and inform better treatment options for those with breast cancer.